HIV medications come in a wide range of shapes, sizes, and colors, and no single description covers them all. A person taking a once-daily single-tablet regimen might swallow a small yellow oval, while someone on an older multi-pill regimen could be handling a mix of blue capsule-shaped tablets and white round ones. The physical appearance of each pill is determined by its manufacturer, its active ingredients, and the film coating applied during production. Because appearances vary so much across brands and generics, knowing what your specific medication should look like is one practical way to confirm you have the right prescription in hand.
Common Single-Tablet Regimens and What They Look Like
Most people newly diagnosed with HIV today are prescribed a single-tablet regimen, meaning all of the necessary active drugs are combined into one pill taken once a day. This approach became standard after the introduction of the first all-in-one HIV pill in 2006, which combined efavirenz, emtricitabine, and tenofovir disoproxyl fumarate into a single dose and transformed how treatment was delivered.1PubMed Central. The transformation of HIV therapy: One pill once a day That first combination tablet was a pink, capsule-shaped pill. Since then, manufacturers have introduced several newer single-tablet options, each with its own distinct look.
Biktarvy, one of the most widely prescribed HIV medications today, is a purplish-brown, capsule-shaped tablet debossed with “GSI” on one side and “B/F/TAF” on the other. Triumeq is a purple, biconvex oval tablet stamped with “572 TrÑ–.” Dovato, a two-drug regimen in one tablet, is a yellow oval marked “SV 137.” Symtuza is a yellow-beige, capsule-shaped tablet with “8121” on one side and “GSI” on the other. Juluca, another two-drug option, is a pink oval. Each of these tablets is sized differently, too. Newer formulations tend to be noticeably smaller than older ones, which matters when you are swallowing one every single day.
For pre-exposure prophylaxis, commonly called PrEP, the two main oral options also look quite different from each other. Truvada is a blue, capsule-shaped tablet imprinted with “701” and “GILEAD” on opposite sides. Descovy, its newer counterpart, is a smaller blue rectangular tablet with rounded edges. Both are coated in that distinctive blue, but the size difference between the two is easy to spot side by side.
Why HIV Pills Come in Different Colors and Coatings
The colors of HIV tablets are not random or purely cosmetic. Pharmaceutical film coating serves multiple purposes: it improves the taste and smell of the tablet, protects the active ingredients from moisture and light, and can control how the drug is released once swallowed.2PubMed Central. A Comprehensive Review on Pharmaceutical Film Coating: Past, Present, and Future The specific color of a coating often comes from iron oxides, which produce yellows, reds, and browns, or from titanium dioxide, a widely used opacifying agent that gives tablets a white or pastel appearance.3PubMed. Stability impact from a titanium dioxide-free film-coated tablet: An analytical investigation into photo-, physical, and chemical stability of compressed tablets made with alternative film-coating materials
Color also helps with identification. Manufacturers deliberately choose distinct colors and imprint codes so that patients, pharmacists, and caregivers can tell pills apart at a glance. When you open your bottle and see the same familiar color and shape every day, that consistency is a simple safety check. If something looks different, it could mean a pharmacy dispensed a generic version with different coatings, or it could signal a dispensing error worth flagging.
Generic HIV Medications May Look Different
One of the most common sources of confusion is that generic versions of the same drug often look nothing like the brand-name tablet. Generic manufacturers choose their own coatings, colors, shapes, and imprint codes. A person who has been taking a blue capsule-shaped tablet for years might receive a white round one after their pharmacy switches to a different generic supplier. The active ingredients inside are bioequivalent, meaning they deliver the same drug at the same levels in your body, but the pill in your hand can look completely unfamiliar.
This is especially common in countries where large-scale generic production serves public health programs. The generic versions distributed through international programs may be round white tablets with no recognizable branding, or they may carry imprint codes specific to the generic manufacturer. If you receive a refill that looks different from your previous supply, it is worth confirming the change with your pharmacist rather than assuming something went wrong. At the same time, do not stop taking your medication just because the pill looks new.
Pill Size, Shape, and Why They Affect Adherence
The physical characteristics of HIV pills are not just an identification issue. They directly affect whether people take their medication consistently. In a study of nearly 400 people living with HIV, about a quarter reported skipping doses because of what researchers called pill aversion: gagging, nausea at the moment of swallowing, or being bothered by the taste, smell, or size of the pills.4PubMed Central. Understanding HIV-Related Pill Aversion as a Distinct Barrier to Medication Adherence People who skipped doses for these reasons were also more likely to report negative emotions around the act of pill-taking itself.
This is why pharmaceutical companies have invested heavily in shrinking the size of HIV tablets over successive generations. Older combination pills could be quite large because they packed three drugs with high milligram doses into a single tablet. Newer formulations use more potent active ingredients at lower doses, or use updated salt forms of the same drug that require less bulk. The result is a noticeably smaller pill. For someone who struggles with swallowing, the difference between a large oblong tablet and a compact oval one can be the difference between consistent adherence and missed doses.
Can You Crush or Split HIV Tablets
People who have difficulty swallowing pills sometimes wonder whether they can crush an HIV tablet and mix it into food or a drink. The answer depends entirely on which medication you are taking. Some film-coated tablets are designed to be swallowed whole because the coating protects the drug from stomach acid or controls its release rate. Crushing those tablets can change how much drug your body absorbs and how quickly.
One well-studied example is Biktarvy. In a clinical crossover study, crushing the tablet and mixing it with water changed the absorption profile. The overall exposure to bictegravir remained equivalent whether the tablet was swallowed whole or crushed, but emtricitabine and tenofovir alafenamide showed lower peak levels when the tablet was crushed.5Journal of Antimicrobial Chemotherapy. Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study In practical terms, the total amount of drug absorbed over time was close enough for bictegravir and emtricitabine, but the peak blood levels of two of the three components were lower than expected. Whether that matters clinically depends on the patient, and it is something to discuss with a prescriber before doing routinely.
Other HIV medications, particularly some protease inhibitors, should never be crushed because doing so can cause a bitter, unpleasant taste or alter the drug’s effectiveness. Always check with your pharmacist before modifying any tablet.
Pediatric Formulations Look Very Different
Children living with HIV often cannot swallow adult-sized tablets, so manufacturers produce alternative formulations that look and function quite differently from what adults take. These include flavored liquid syrups, dissolvable tablets, granules that can be sprinkled on food, and tiny pellets sometimes called minitabs.
A study evaluating children’s preferences for lopinavir/ritonavir found that younger children initially preferred pellets over syrups, in part because pellets did not require refrigeration and were easier for caregivers to transport.6PubMed Central. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children However, taste remained a challenge: roughly a third or more of young children found both pellets and syrups unpleasant to take. Among older children who could swallow tablets, the tablets were strongly preferred over pellets because they had almost no taste at all. This tracks with what most adults experience: a coated tablet that goes down in one swallow is far easier than a formulation you have to taste on the way down.
Parents and caregivers handling pediatric HIV formulations should know that these products look nothing like the adult pills. Syrups come in amber bottles. Pellet capsules may need to be opened and the contents sprinkled onto soft food. Dispersible tablets dissolve in a small amount of water. If you are identifying an unfamiliar pediatric HIV medication, the packaging and delivery method are often more useful clues than the medication’s appearance alone.
Storing HIV Pills and the Desiccant Packet
When you open a bottle of HIV medication, you will almost certainly find a small packet or canister of desiccant inside. That desiccant is not packaging waste. For dolutegravir-containing formulations specifically, stability testing has shown that the desiccant provides a meaningful protective benefit against moisture degradation, and it should stay in the bottle even after the first opening.7PubMed Central. Preliminary Evaluation of Stability Data for Dolutegravir-Containing Triple Active Formulations Intended for PEPFAR Removing it and throwing it away, which many people instinctively do, can shorten the usable life of the pills, especially in warm or humid climates.
Beyond the desiccant, most HIV tablets should be stored at room temperature and kept away from direct sunlight. The film coatings that give tablets their colors also serve as a physical barrier against light and moisture, but they are not invincible. If your tablets start to look discolored, chalky, crumbling, or different from how they usually appear, that is a signal to check with your pharmacist about whether the medication is still safe to take. Changes in smell can also indicate degradation, though this is less common with coated tablets.
Using Imprint Codes to Verify Your Medication
Every prescription tablet sold in the United States is required to carry a unique imprint, which is a combination of letters, numbers, or a logo debossed or printed on the surface. This imprint, combined with the pill’s color, shape, and size, makes it possible to positively identify the medication. The FDA maintains the National Drug Code directory, and several online pill identifier tools allow you to type in what you see on a tablet and get a match.
For HIV medications, some commonly seen imprints include “GSI” for Gilead Sciences products, “SV” followed by a number for ViiV Healthcare products, and various numeric codes unique to each formulation. If you find an unmarked tablet, it is not a commercially manufactured prescription drug sold in the U.S., as the imprint requirement applies to all finished dosage forms. Unmarked tablets could be over-the-counter supplements, foreign generics, or something else entirely. Never assume an unmarked pill is an HIV medication.
When traveling or refilling prescriptions in a different country, the imprint codes on generics may be unfamiliar. In those situations, confirm the pill identity through your pharmacy or by checking the manufacturer’s patient information sheet, which usually includes a photograph or detailed physical description of the tablet.
Long-Acting Injectables as an Alternative
Not all HIV treatment involves pills anymore. Cabotegravir, a potent integrase inhibitor, has been developed both as a daily oral tablet and as a long-acting injectable nanosuspension.8PubMed Central. Formulation and pharmacology of long-acting cabotegravir When paired with rilpivirine in its injectable form, the combination is given as two intramuscular injections (one in each buttock) every one or two months, replacing daily pills entirely.
For people with pill aversion, swallowing difficulties, or concerns about privacy, the injectable option removes the daily visual reminder of medication. There is no pill to identify, no bottle to store, and no desiccant to worry about. However, the oral tablet form of cabotegravir does exist and is sometimes used as a lead-in period before starting injections. That tablet is a small, oval, white film-coated pill. It looks unremarkable compared to the more colorful branded single-tablet regimens, which sometimes causes confusion for patients transitioning between formulations.
When Appearance Raises Privacy Concerns
For some people, the distinctive look of their HIV medication is itself a concern. A brightly colored, uniquely shaped tablet sitting on a nightstand or pulled from a bag at lunch is potentially recognizable to anyone who has seen an ad or a pharmacy display. This is not a trivial worry. Stigma around HIV remains real, and some people have reported adjusting when and where they take their medication to avoid being seen with identifiable pills.
Manufacturers are not unaware of this issue. The trend toward smaller, more neutral-looking tablets partly reflects an understanding that patients benefit from medications that do not draw attention. Some people transfer their pills to unmarked containers, though doing so means losing the pharmacy label that confirms the medication and dose. A middle ground is using a daily pill organizer, which holds the tablet without displaying its branded bottle but still keeps it in a controlled environment.
Travel introduces additional considerations. Some countries have laws or social attitudes around HIV that make carrying identifiable medication risky. In those situations, keeping pills in their original labeled container provides legal protection (it proves you have a legitimate prescription), even though it also makes the medication identifiable. There is no universal answer here, and individuals often develop their own strategies balancing privacy, safety, and legal requirements depending on context.